scholarly journals Occult lymph node metastasis in laryngeal squamous cell carcinoma: Therapeutic and prognostic impact

2010 ◽  
Vol 127 (5) ◽  
pp. 173-176 ◽  
Author(s):  
M. Mnejja ◽  
B. Hammami ◽  
L. Bougacha ◽  
A. Chakroun ◽  
I. Charfeddine ◽  
...  
Head & Neck ◽  
2014 ◽  
Vol 37 (4) ◽  
pp. 479-486 ◽  
Author(s):  
Natalie Kelner ◽  
Priscila Campioni Rodrigues ◽  
Andreia Bufalino ◽  
Felipe Paiva Fonseca ◽  
Alan Roger dos Santos-Silva ◽  
...  

2019 ◽  
Vol 10 (12) ◽  
Author(s):  
Pei Li ◽  
Xi-Jun Lin ◽  
Yang Yang ◽  
An-Kui Yang ◽  
Jin-Ming Di ◽  
...  

AbstractThe burgeoning functions of many microRNAs (miRs) have been well study in cancer. However, the level and function of miR-1205 in laryngeal squamous cell cancer remains unknown. In the current research, we validated that miR-1205 was notably downregulated in human laryngeal squamous cell carcinoma (LSCC) samples in comparison with tissues adjacent to LSCC, and correlated with T stage, lymph node metastasis, and clinical stage. Using Kaplan–Meier analysis indicates that high expression of miR-1205 has a favorable prognosis for patients with LSCC. Functional assays show that enforced miR-1205 expression attenuates the migration, growth, and invasion of LSCC cells. And E2F1 is verified to be a target of miR-1205, while E2F1 binds to miR-1205 promoter and transcriptionally inhibits miR-1205 expression. Overexpression of E2F1 reverses the inhibitory impacts of miR-1205 on LSCC cells in part. Importantly, E2F1 is abnormally increased in LSCC tissues, and its protein levels were inversely relevant to miR-1205 expression. High E2F1 protein level is in connection with clinical stage, T stage, lymph node metastasis, and poor prognosis. Consequently, reciprocal regulation of miR-1205 and E2F1 plays a crucial role in the progression of LSCC, suggesting a new miR-1205/E2F1-based clinical application for patients of LSCC.


2018 ◽  
Vol 160 (2) ◽  
pp. 277-283 ◽  
Author(s):  
Maxime Mermod ◽  
Massimo Bongiovanni ◽  
Tatiana Petrova ◽  
Elena Goun ◽  
Christian Simon ◽  
...  

Objective The management of occult lymph node metastasis (LNM) in head and neck squamous cell carcinoma has been a matter of controversy for decades. The vascular density within the tumor microenvironment, as an indicator of ongoing angiogenesis, could constitute an attractive predictor of LNM. The use of the panvascular endothelial antibody CD31 as a marker of occult LNM has never been reported. The aim of this study was to assess the predictive value of CD31 microvascular density for the detection of occult LNM in squamous cell carcinoma of the oral cavity and oropharynx. Study Design Case series with chart review. Setting Tertiary university hospital. Subjects and Methods Intra- and peritumoral microvascular density values were determined in 56 cases of squamous cell carcinoma of the oral cavity (n = 50) and oropharynx (n = 6) with clinically negative necks using the CD31 marker. Statistical associations of CD31 microvascular densities with clinicopathologic data were then established. Results Peritumoral CD31 microvascular density was significantly associated with occult LNM in multivariate analysis ( P < .01). Recursive partitioning analysis for this parameter found a cutoff of 19.33, which identified occult LNM with a sensitivity of 91%, a specificity of 65%, a positive predictive value of 40%, a negative predictive value of 97%, and an overall diagnostic accuracy of 71%. Conclusion Peritumoral CD31 microvascular density in primary squamous cell carcinoma of the oral cavity and oropharynx allows accurate prediction of occult LNM.


Sign in / Sign up

Export Citation Format

Share Document